Fund shareholders of Oruka Therapeutics Inc
ISIN US6876041087 · United States · LEI 529900TG7O4ESUDMGI54
- Fund shareholders
- 171
- Of which ETFs
- 35 136 other funds
- Value held
- 717.5M $
- Share of capital
- 20.8 % of 66.2M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 4,675 | 160.9K $ | 0.13 % | 0.01 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Small-Cap Index Fund T. ROWE PRICE INDEX TRUST, INC. | 4,669 | 229K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Discovery Fund Fidelity Concord Street Trust | 4,500 | 307.8K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| SA Small Cap Index Portfolio SUNAMERICA SERIES TRUST | 4,200 | 287.3K $ | 0.08 % | 0.01 % | as of Apr 30, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 4,161 | 204.1K $ | 0.49 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Voya RussellTM Small Cap Index Portfolio Voya VARIABLE PORTFOLIOS INC | 4,103 | 201.3K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Small Cap Discovery Fund Fidelity Concord Street Trust | 4,000 | 273.6K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Small Cap Value Insights Fund Goldman Sachs Trust | 3,850 | 263.4K $ | 0.02 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 3,849 | 263.3K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Multi-Manager U.S. Small Cap Equity Fund Goldman Sachs Trust II | 3,840 | 262.7K $ | 0.07 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 3,559 | 122.5K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 3,452 | 169.3K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 3,354 | 164.5K $ | 0.13 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PGIM Quant Solutions Small-Cap Value Fund Target Portfolio Trust | 3,200 | 218.9K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Vericimetry U.S. Small Cap Value Fund VERICIMETRY FUNDS | 3,154 | 154.7K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| CVT Russell 2000 Small Cap Index Portfolio Calvert Variable Trust, Inc. | 3,132 | 153.6K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 3,121 | 107.4K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nationwide Small Cap Index Fund Nationwide Mutual Funds | 3,106 | 212.5K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 3,065 | 105.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 2,900 | 142.2K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 2,825 | 138.6K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 2,807 | 192K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 2,692 | 92.6K $ | 0.12 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 2,690 | 131.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| NYLIM VP Wellington Small Cap Portfolio NEW YORK LIFE INVESTMENTS VP FUNDS TRUST | 2,486 | 121.9K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 2,414 | 118.4K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Institutional Small-Cap Equity Fund STATE STREET INSTITUTIONAL FUNDS | 2,390 | 117.2K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 2,388 | 82.2K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 2,383 | 82K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,236 | 76.9K $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| NORTH SQUARE KENNEDY MICROCAP FUND Exchange Place Advisors Trust | 2,156 | 74.2K $ | 0.25 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Harbor Health Care ETF Harbor ETF Trust | 1,846 | 126.3K $ | 0.46 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 1,751 | 60.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 1,727 | 84.7K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 1,674 | 57.6K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 1,616 | 79.3K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 1,592 | 54.8K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 1,553 | 106.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,284 | 63K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 1,249 | 85.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 1,241 | 84.9K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 1,182 | 80.9K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,100 | 54K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 907 | 44.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 897 | 61.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 876 | 43K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 850 | 29.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 791 | 38.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 757 | 26K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 719 | 35.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 672 | 33K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Lord Abbett Health Care Fund LORD ABBETT SECURITIES TRUST | 603 | 41.3K $ | 0.51 % | 0.00 % | as of Apr 30, 2026 ↗ |
| MFS Global Alternative Strategy Fund MFS Series Trust XV | 585 | 40K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 535 | 26.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 435 | 29.8K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 377 | 25.8K $ | 0.17 % | 0.00 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 238 | 11.7K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 234 | 16K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 222 | 15.2K $ | 0.20 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 208 | 10.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 192 | 9.4K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 129 | 6.3K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Small-Cap Equity V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 113 | 5.5K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 97 | 4.8K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 88 | 4.3K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 70 | 4.8K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 53 | 2.6K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 42 | 2.1K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 40 | 1.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 13 | 447.3 $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 10 | 490.5 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 2.65 % | as of Apr 30, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 2.09 % | as of Apr 30, 2026 ↗ |
| Tactical Growth Allocation Fund Tactical Investment Series Trust | 1.93 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 1.68 % | as of Apr 30, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 1.60 % | as of Apr 30, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 1.44 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.08 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 1.00 % | as of Apr 30, 2026 ↗ |
| Lord Abbett Micro-Cap Growth Fund LORD ABBETT SECURITIES TRUST | 0.88 % | as of Apr 30, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 0.79 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 171 | +39 | 13,771,127 | +11.0 % |
| 2026Q1 | 132 | +23 | 12,405,359 | +26.0 % |
| 2025Q4 | 109 | +25 | 9,849,222 | +3.6 % |
| 2025Q3 | 84 | +43 | 9,508,540 | +20.1 % |
| 2025Q2 | 41 | +8 | 7,918,068 | +32.4 % |
| 2025Q1 | 33 | +17 | 5,981,102 | +199.3 % |
| 2024Q4 | 16 | 1,998,271 |
Institutional managers
176 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 7,431,403 | 364.5M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 4,148,428 | 203.5M $ | as of Mar 31, 2026 |
| Fairmount Funds Management LLC | 3,705,262 | 181.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,527,087 | 173M $ | as of Mar 31, 2026 |
| VIKING GLOBAL INVESTORS LP | 2,666,690 | 130.8M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 2,320,316 | 113.8M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 2,058,148 | 101M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 2,034,203 | 99.8M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,613,461 | 79.1M $ | as of Mar 31, 2026 |
| Remedium Capital Partners, LLC | 1,565,661 | 76.8M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 1,395,501 | 68.4M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 1,047,693 | 51.4M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,007,537 | 49.4M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 1,004,056 | 49.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 954,867 | 46.8M $ | as of Mar 31, 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | 802,470 | 39.4M $ | as of Mar 31, 2026 |
| Avidity Partners Management LP | 760,424 | 37.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 727,449 | 35.7K $ | as of Mar 31, 2026 |
| Woodline Partners LP | 574,882 | 28.2M $ | as of Mar 31, 2026 |
| Cormorant Asset Management, LP | 533,340 | 26.2M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 507,008 | 24.9M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 499,673 | 24.5M $ | as of Mar 31, 2026 |
| Synergy Asset Management, LLC | 476,196 | 23.4M $ | as of Mar 31, 2026 |
| SR One Capital Management, LP | 430,330 | 21.1M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 411,006 | 20.2M $ | as of Mar 31, 2026 |
Declared shareholders of Oruka Therapeutics Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Fairmount Funds Management LLC and 4 others | 19.99 % | 13,665,080 | as of Apr 30, 2026 · SCHEDULE 13D |
| VIKING GLOBAL INVESTORS LP and 9 others | 5.30 % | 2,666,690 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Oruka Therapeutics Inc". https://titelia.com/en/stocks/oruka-therapeutics-inc-US6876041087